BANK OF AMERICA CORP /DE/ - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,219,884
+10.9%
496,593
+153.4%
0.00%0.0%
Q2 2023$9,213,287
-22.7%
195,944
-31.0%
0.00%0.0%
Q1 2023$11,916,681
+26.4%
284,001
+14.9%
0.00%0.0%
Q4 2022$9,428,627
+23.3%
247,211
+26.6%
0.00%0.0%
Q3 2022$7,645,000
+51.8%
195,216
+25.2%
0.00%0.0%
Q2 2022$5,036,000
-36.9%
155,921
-35.3%
0.00%0.0%
Q1 2022$7,980,000
+32.0%
241,088
+69.7%
0.00%0.0%
Q4 2021$6,044,000
+67.8%
142,092
+74.8%
0.00%
Q3 2021$3,602,000
-41.0%
81,302
-24.3%
0.00%
-100.0%
Q2 2021$6,103,000
-6.6%
107,439
+23.0%
0.00%0.0%
Q1 2021$6,537,000
-29.5%
87,329
-18.5%
0.00%0.0%
Q4 2020$9,268,000
+84.7%
107,131
+30.5%
0.00%0.0%
Q3 2020$5,018,000
-18.6%
82,107
-44.6%
0.00%0.0%
Q2 2020$6,166,000
+12.9%
148,300
-22.0%
0.00%0.0%
Q1 2020$5,460,000
-66.0%
190,128
-14.6%
0.00%
-50.0%
Q4 2019$16,064,000
-54.2%
222,522
-10.9%
0.00%
-60.0%
Q3 2019$35,036,000
-14.8%
249,751
+11.2%
0.01%
-16.7%
Q2 2019$41,121,000
-7.9%
224,601
-20.0%
0.01%
-14.3%
Q1 2019$44,652,000
+184.2%
280,742
+71.2%
0.01%
+133.3%
Q4 2018$15,709,000
-46.6%
164,000
-21.3%
0.00%
-40.0%
Q3 2018$29,435,000
-0.9%
208,385
+9.8%
0.01%0.0%
Q2 2018$29,703,000
+111.3%
189,764
+117.4%
0.01%
+150.0%
Q1 2018$14,060,000
-84.3%
87,289
-84.0%
0.00%
-86.7%
Q4 2017$89,617,000
+457.6%
544,090
+110.9%
0.02%
+400.0%
Q3 2017$16,073,000
+95.6%
258,012
+150.1%
0.00%
+50.0%
Q2 2017$8,217,000
+167.8%
103,182
+139.1%
0.00%
+100.0%
Q1 2017$3,068,000
+20.9%
43,162
-13.2%
0.00%0.0%
Q4 2016$2,538,000
+30.4%
49,734
+17.6%
0.00%
Q3 2016$1,947,000
-4.0%
42,296
-37.2%
0.00%
Q2 2016$2,028,000
+4.7%
67,302
+11.4%
0.00%
Q1 2016$1,937,000
-47.0%
60,398
-3.7%
0.00%
-100.0%
Q4 2015$3,657,000
+145.8%
62,729
+78.3%
0.00%
Q3 2015$1,488,000
+190.1%
35,184
+400.8%
0.00%
Q2 2015$513,000
+4175.0%
7,026
+2915.5%
0.00%
Q1 2015$12,000
+9.1%
233
-22.3%
0.00%
Q4 2014$11,0003000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders